METASTATIC LIVER CANCER
Clinical trials for METASTATIC LIVER CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC LIVER CANCER trials appear
Sign up with your email to follow new studies for METASTATIC LIVER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on liver cancer in new trial
Disease control Recruiting nowThis study tests a new treatment called ECT204 for adults with advanced liver cancer that has not responded to standard therapy. The treatment uses the patient's own immune cells, which are modified in a lab to better recognize and attack cancer cells. The trial will enroll 60 pe…
Matched conditions: METASTATIC LIVER CANCER
Phase: PHASE1, PHASE2 • Sponsor: Eureka Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New drug ERX-315 enters first human tests for tough cancers
Disease control Recruiting nowThis early-stage trial tests the safety of a new drug called ERX-315 in 36 adults with advanced solid tumors (like breast, ovarian, or pancreatic cancer) that have stopped responding to standard treatments. Participants receive the drug intravenously twice a week at increasing do…
Matched conditions: METASTATIC LIVER CANCER
Phase: PHASE1 • Sponsor: EtiraRx Australia Pty Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New radioactive drug targets Hard-to-Treat liver cancer
Disease control Recruiting nowThis pilot study tests a radioactive drug called 177Lu-PSMA-617 in 10 patients with PSMA-positive liver cancer that has spread. The goal is to see if the drug is safe and can shrink tumors. Patients must have already tried one prior treatment.
Matched conditions: METASTATIC LIVER CANCER
Phase: PHASE2 • Sponsor: Melissa Lumish • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Engineered immune cells take on Hard-to-Treat liver cancer
Disease control Recruiting nowThis study tests a new treatment for adults with advanced liver cancer that cannot be removed by surgery or has spread. The treatment uses specially engineered immune cells (CAR-NK cells) from a healthy donor, designed to target two proteins found on liver cancer cells. Participa…
Matched conditions: METASTATIC LIVER CANCER
Phase: PHASE1, PHASE2 • Sponsor: Beijing Biotech • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Supercharged immune cells take on advanced cancers
Disease control Recruiting nowThis early-phase trial is testing a new therapy called Meta10-TIL for people with advanced solid tumors that have not responded to at least one prior treatment. The therapy uses a patient's own tumor-fighting immune cells, which are modified in the lab to work better, and then gi…
Matched conditions: METASTATIC LIVER CANCER
Phase: EARLY_PHASE1 • Sponsor: Anhui Provincial Hospital • Aim: Disease control
Last updated Jun 26, 2026 16:55 UTC